CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. to Announce Second Quarter 2019 Results on August 6, 2019
23 juil. 2019 08h45 HE | CV Sciences, Inc.
SAN DIEGO, July 23, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that it will release financial results for its second...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Expands Operations with New Production and Warehousing Facility to Support Worldwide Growth Opportunities
16 juil. 2019 08h45 HE | CV Sciences, Inc.
Facility Expansion Increases Hemp CBD Oil Production and Warehousing/Fulfillment Capacity by More Than 500 Percent SAN DIEGO, July 16, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Announces Commitment to More Than 500 Acres of U.S. Hemp Production for 2019
10 juil. 2019 10h14 HE | CV Sciences, Inc.
Hemp CBD Pioneer Ramps Up Domestic Supply to Meet Growing Retailer and Consumer Demand SAN DIEGO, July 10, 2019 (GLOBE NEWSWIRE) --  CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”,...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. to Present at Upcoming Investor Conferences
07 mai 2019 08h45 HE | CV Sciences, Inc.
LAS VEGAS, May 07, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) a preeminent supplier and manufacturer of hemp CBD products through its...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Appoints Deloitte & Touche LLP as Auditor
15 avr. 2019 16h00 HE | CV Sciences, Inc.
LAS VEGAS, April 15, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products,...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Appoints Joerg Grasser as New Chief Financial Officer
21 mars 2019 17h00 HE | CV Sciences, Inc.
LAS VEGAS, March 21, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products through...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Reports Fiscal Year-End 2018 Financial Results
12 mars 2019 16h05 HE | CV Sciences, Inc.
Record full year revenue LAS VEGAS, March 12, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (“CV Sciences” or the “Company”) announced today its financial results for the year ended...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Appoints Dr. Douglas MacKay as Senior Vice President of Scientific and Regulatory Affairs
01 mars 2019 08h45 HE | CV Sciences, Inc.
LAS VEGAS, March 01, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of industry-dominating hemp...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. to Present and Exhibit at Natural Products Expo West 2019 in Anaheim, California, March 5-9, 2019
27 févr. 2019 08h45 HE | CV Sciences, Inc.
Company enters its 4th year exhibiting at the nation's largest natural products trade show, offering natural health retailers show specials, one-on-one education, and a wide selection of product...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. to Announce Fourth Quarter and Full Year 2018 Results on March 12, 2019
26 févr. 2019 08h45 HE | CV Sciences, Inc.
LAS VEGAS, Feb. 26, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that it will release financial results for its fourth...